Sangamo Therapeutics Inc (SGMO) Business News Dec. 18, 2025, 13:05 UTC Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease Full text
There are no comments here yet...